Ischemic and postischemic conditioning of the myocardium in clinical practice: Challenges, expectations and obstacles

Cardiology (Switzerland)

Volumn 129, Issue 2, 2014, Pages 117-125

  Iliodromitis, Efstathios K ^a   Andreadou, Ioanna ^b   Iliodromitis, Konstantinos E ^c   Dagres, Nikolaos ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c ELISABETH KRANKENHAUS ESSEN   (Germany)

Author keywords

Ischemia; Perconditioning; Postconditioning; Preconditioning; Remote conditioning; Reperfusion injury

Indexed keywords

ARTICLE; CARDIAC PATIENT; CLINICAL PRACTICE; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE; HEART PROTECTION; HUMAN; ISCHEMIC CONDITIONING; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; METHODOLOGY; PHARMACEUTICAL CARE; HEART MUSCLE REPERFUSION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PROCEDURES;

ADENOSINE; CYCLOSPORIN; ENZYME ACTIVATOR; ERYTHROPOIETIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NICORANDIL; VASODILATOR AGENT;

ADENOSINE; CYCLOSPORINE; ENZYME ACTIVATORS; ERYTHROPOIETIN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INSULIN; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; NICORANDIL; VASODILATOR AGENTS;

EID: 84908502441     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000362499     Document Type: Article

References (61)

1. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
2. van Winkle DM, Thornton JD, Downey JM: Cardioprotection from ischemic preconditioning is lost following prolonged reperfusion in the rabbit. Coron Artery Dis 1991; 2: 613-619.
3. Iliodromitis EK, Kremastinos DT, Katritsis DG, Papadopoulos CC, Hearse DJ: Multiple cycles of preconditioning cause loss of protection in open-chest rabbits. J Mol Cell Cardiol 1997; 29: 915-920.
4. Li Y, Kloner RA: Cardioprotective effects of ischemic preconditioning can be recaptured after they are lost. J Am Coll Cardiol 1994; 23: 470-474.
5. Iliodromitis EK, Papadopoulos C, Paraskevaidis IA, Kyriakides ZS, Flessa C, Kremastinos DT: Protection from preconditioning can be reinstated at various reperfusion intervals. Cardiovasc Drugs Ther 1996; 10: 341-346.
6. Yellon DM, Baxter GF: A 'second window of protection' or delayed preconditioning phenomenon: future horizons for myocardial protection? J Mol Cell Cardiol 1995; 27: 1023- 1034.
7. Liu GS, Thornton J, van Winkle DM, Stanley AWH, Olsson RA, Downey JM: Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350-356.
8. Liu Y, Ytrehus K, Downey JM: Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 1994; 26: 661-668.
9. Schulz R, Cohen MV, Behrends M, Downey JM, Heusch G: Signal transduction of ischemic preconditioning. Cardiovasc Res 2001; 52: 181-198.
10. Parratt JR: Possibilities for the pharmacological exploitation of ischemic preconditioning. J Mol Cell Cardiol 1995; 27: 991-1000.
11. Leesar MA, Stoddard MF, Manchikalapudi S, Bolli R: Bradykinin-induced preconditioning in patients undergoing coronary angioplasty. J Am Col Cardiol 1999; 34: 639-650.
12. Kloner RA, Shook T, Przyklenk K, Davis VG, Junio L, Matthews RV, Burstein S, Gibson M, Poole WK, Cannon CP, et al: Previous angina alters in hospital outcome in TIMI 4: A clinical correlate to preconditioning? Circulation 1995; 91: 37-45.
13. Ottani F, Galvani M, Ferrini D, Sorbello F, Limonetti P, Pantoli D, Rusticali F: Prodromal angina limits infarct size: A role for ischemic preconditioning. Circulation 1995; 91: 291-297.
14. Cohen MV, Liu GS, Downey JM: Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 1991; 84: 341- 349.
15. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Kurisu S, Sakai K, Ueda K: Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: Acute angiographic findings and long-term prognosis. J Am Coll Cardiol 1997; 30: 970-975.
16. Iliodromitis EK, Kyrzopoulos S, Paraskevaidis IA, Kolocassides KG, Adamopoulos S, Karavolias G, Kremastinos DT: Increased C reactive protein and cardiac enzyme levels after coronary stent implantation: is there protection by remote ischaemic preconditioning? Heart 2006; 92: 1821-1826.
17. Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O'Sullivan M, Dutka DP: Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: A prospective, randomized control trial. Circulation 2009; 119: 820-827.
18. Rahman IA, Mascaro JG, Steeds RP, Frenneaux MP, Nightingale P, Gosling P, Townsend P, Townend JN, Green D, Bonser RS: Remote ischemic preconditioning in human coronary artery bypass surgery. Circulation 2010; 122(suppl 1):S53-S59.
19. Oldenburg O, Qin Q, Krieg T, Yang XM, Philipp S, Critz SD, Cohen MV, Downey JM: Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol 2004; 286:H468-H476.
20. Crisostomo PR, Wairiuko GM, Wang M, Tsai BM, Morrell ED, Meldrum DR: Preconditioning versus postconditioning: mechanisms and therapeutic potentials. J Am Coll Surg 2006; 202: 797-812.
21. Kloner RA, Rezkalla SH: Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc Res 2006; 70: 297-307.
22. Edwards RJ, Redwood SR, Lambiase PD, Tomset E, Rakhit RD, Marber MS: Antiarrhythmic and anti-ischaemic effects of angina in patients with and without coronary collaterals. Heart 2002; 88: 604-610.
23. Laskey WK: Beneficial impact of preconditioning during PTCA on creatinine kinase release. Circulation 1999; 99: 2085-2099.
24. Iliodromitis EK, Koutelou M, Paraskevaidis IA, Theodorakos A, Farmakis D, Tsoutsanis J, Kremastinos DT: Treadmill exercise test with dual isotope scintigraphy documents the second window of protection in humans. Atherosclerosis 2008; 198: 122-128.
25. Mahaffey KW, Puma JA, Barbagelata NA, Di-Carli MF, Leesar MA, Browne KF, Eisenberg PR, Bolli R, Casas AC, Molina-Viamonte V, Orlandi C, Blevins R, Gibbons RJ, Califf RM, Granger CB: Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: The Acute Myocardial Infarction Study of Adenosine (AMISTAD) trial. J Am Coll Cardiol 1999; 34: 1711-1720.
26. Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW: A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD II). J Am Coll Cardiol 2005; 45: 1775-1780.
27. IONA Study Group: Effect of nicorandil on coronary events in patients with stable angina: The Impact of Nicorandil in Angina Randomized trial. Lancet 2002; 359: 1269-1275.
28. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P: Regional ischemic preconditioning protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993; 87: 893-899.
29. Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M: STAT5 activation and cardioprotection by remote ischemic preconditioning in humans. Circ Res 2012; 110: 111-115.
30. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J: Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285:H579-H588.
31. Iliodromitis EK, Georgiadis M, Cohen MV, Downey JM, Bofilis E, Kremastinos DT: Protection from postconditioning depends on the number of short ischemic insults in anesthetized pigs. Basic Res Cardiol 2006; 101: 502-507.
32. Yellon DM, Hausenloy DJ: Myocardial reperfusion injury. New Engl J Med 2007; 357: 1121-1135.
33. Schwartz Longarce L, Kloner RA, Arai AE, Baines CP, Bolli R, Braunwald E, Downey J, Gibbons RJ, Gottlieb RA, Heusch G, Jennings RB, Lefer DJ, Mentzer RM, Murphy E, Ovize M, Ping P, Przyklenk K, Sack MN, Van der Heide RS, Vinten-Johansen J, Yellon DM, National Heart, Lung, and Blood Institute, National Institutes of Health: New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation 2011; 124: 1172-1179.
34. Downey JM, Cohen MV: Reducing infarct size in the setting of acute myocardial infarction. Prog Cardiovasc Dis 2006; 48: 363-371.
35. Kerendi F, Kin H, Halkos ME, Jiang R, Zatta AJ, Zhao ZQ, Guyton RA, Vinten-Johansen J: Remote postconditioning: brief renal ischemia and reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors. Basic Res Cardiol 2005; 100: 404-412.
36. Andreka G, Vertesaljai M, Szantho G, Font G, Piroth Z, Fontos G, Juhasz ED, Szekely L, Szelid Z, Turner MS, Ashrafian H, Frenneaux MP, Andreka P: Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs. Heart 2007; 93: 749-752.
37. Gritsopoulos G, Iliodromitis EK, Zoga A, Farmakis D, Demerouti E, Papalois A, Paraskevaidis IA, Kremastinos DT: Remote postconditioning is more potent than classic postconditioning in reducing the infarct size in anesthetized rabbits. Cardiovasc Drugs Ther 2009; 23: 193-198.
38. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, Aupetit JF, Bonnefoy E, Finet G, Andre-Fouet X, Ovize M: Postconditioning the human heart. Circulation 2005; 112: 2143- 2148.
39. Iliodromitis EK, Paraskevaidis IA, Fountoulaki K, Farmakis D, Andreadou I, Antoniadis A, Ikonomidis I, Leftheriotis D, Kremastinos DT: Staccato reperfusion prevents reperfusion injury in patients undergoing coronary angioplasty: A 1-year follow-up pilot study. Atherosclerosis 2009; 204: 497-502.
40. Hausenloy DJ, Baxter G, Bell R, Botker HE, Davidson SM, Downey J, Heusch G, Kitakaze M, Lecour S, Mentzer R, Mocanu MM, Ovize M, Schulz R, Shannon R, Walker M, Walkinshaw G, Yellon DM: Translating novel strategies for cardio-protection: The Hatter Workshop Recommendations. Basic Res Cardiol 2010; 105: 677-686.
41. Hausenloy DJ, Yellon DM: Preconditioning and postconditioning: new strategies for cardioprotection. Diabetes Obes Metab 2008; 10: 451-459.
42. Burley DS, Baxter GF: Pharmacological targets revealed by myocardial postconditioning. Curr Opinion Pharmacol 2009; 9: 177- 188.
43. Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R: Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 2010: 105: 771-785.
44. Hausenloy DJ, Yellon DM: Reperfusion injury salvage kinase signalling: Taking a RISK for cardioprotection. Heart Fail Rev 2007; 12: 217-234.
45. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, Andre-Fouet X, Revel D, Kirkorian G, Monassier JP, Derumeaux G, Ovize M: Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 2008; 359: 473- 481.
46. Hausenloy DJ, Iliodromitis EK, Andreadou I, Papalois A, Gritsopoulos G, Anastasiou-Nana M, Kremastinos DT, Yellon DM: Investigating the signal transduction pathways underlying remote ischemic conditioning in the porcine heart. Cardiovasc Drugs Ther 2012; 26: 87-93.
47. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sorensen HT, Redington AN, Nielsen TT: Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: A randomized trial. Lancet 2010; 375: 727-734.
48. Freixa X, Bellera N, Ortiz-Perez JT, Jimenez M, Pare C, Bosch X, De Caralt TM, Betriu A, Masotti M: Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J 2012; 33: 103-112.
49. Hahn JY, Song YB, Kim EK, Yu CW, Bae JW, Chung WY, Choi SH, Choi JH, Bae JH, An KJ, Park JS, Oh JH, Kim SW, Hwang JY, Ryu JK, Park HS, Lim DS, Gwon HC: Ischemic postconditioning during primary percutaneous coronary intervention: The effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial. Circulation 2013; 128: 1889-1894.
50. Skyschally A, van Caster P, Iliodromitis EK, Schulz R, Kremastinos DT, Heusch G: Ischemic postconditioning: experimental models and protocol algorithms. Basic Res Cardiol 2009; 104: 469-483.
51. Okamoto F, Allen BS, Buckberg GD, Bugyi H, Leaf J: Reperfusion conditions: importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion. J Thorac Cardiovasc Surg 1986; 92: 613-620.
52. Iliodromitis EK, Andreadou I, Prokovas E, Zoga A, Farmakis D, Fotopoulou T, Ioannidis K, Paraskevaidis IA, Kremastinos DT: Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation. Basic Res Cardiol 2010; 105: 193- 203.
53. Sloth AD, Schmidt MR, Munk K, Kharbanda RK, Redington AN, Schmidt M, Pedersen L, Sorensen HT, Botker HE, CONDI Investigators: Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. Eur Heart J 2014; 35: 168-175.
54. Crimi G, Pica S, Raineri C, Bramucci E, De Ferrari GM, Klersy C, Ferlini M, Marinoni B, Repetto A, Romeo M, Rosti V, Massa M, Raisaro A, Leonardi S, Rubartelli P, Oltrona Visconti L, Ferrario M: Remote ischemic post-conditioning of the lower limb during percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction. JACC Cardiovasc Interv 2013; 6: 1055-1063.
55. Thielman M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, Price V, Tsagakis K, Neuhauser M, Peters J, Jakob H, Heusch G: Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: A single-center randomised, double-blind, controlled trial. Lancet 2013; 382: 597-604.
56. Karuppasamy P, Chanbey S, Dew T, Musto R, Sherwood R, Desai J, John L, Shah AM, Marber MS, Kunst G: Remote intermittent ischemia before coronary bypass graft surgery: A strategy to reduce injury and inflammation? Basic Res Cardiol 2011; 106: 511-519.
57. Hong DM, Lee EH, Kim HJ, Min JJ, Chin JH, Choi DK, Bahk JH, Sim JY, Choi IC, Jeon Y: Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote ischaemic preconditioning with postconditioning trial. Eur Heart J 2014; 35: 176- 183.
58. Hausenloy DJ, Candilio L, Laing C, Kunst G, Pepper J, Kolvekar S, Evans R, Robertson S, Knight R, Ariti C, Clayton T, Yellon DM, ERICCA Trial Investigators: Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial. Clin Res Cardiol 2012; 101: 339-348.
59. Meybohm P, Zacharowski K, Cremer J, Roesner J, Kletzin F, Schaelte G, Felzen M, Strouhal U, Reyher C, Heringlake M, Schon J, Brandes I, Bauer M, Knuefermann P, Wittmann M, Hachenberg T, Schilling T, Smul T, Maisch S, Sander M, Moormann T, Boening A, Weigand MA, Laufenberg R, Werner C, Winterhalter M, Treschan T, Stehr SN, Reinhart K, Hasenclever D, Brosteanu O, Bein B, RIP Heart-Study Investigator Group: Remote ischaemic preconditioning for heart surgery: The study design for a multi-center randomized double-blinded controlled clinical trial - The RIPHeart-Study. Eur Heart J 2012; 33: 1423-1426.
60. Heusch G: Cardioprotection: chances and challenges of its translation to the clinic. Lancet 2013; 381: 166-175.
61. Gerczuk PZ, Kloner RA: An update on cardioprotection: A review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol 2012; 59: 969-978.